Stem-cell-derived extracellular vesicles in neurodegeneration and neuroaging: therapeutic potential and challenges Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.20517/evcna.2025.65
Neuroaging is a complex biological process in which the brain undergoes progressive functional decline marked by synaptic loss, neuroinflammation, and cognitive decline. At the molecular and cellular level, aging is driven by multiple interconnected hallmarks, including genomic instability, telomere attrition, epigenetic alterations, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. Among these, cellular senescence, a state of irreversible cell cycle arrest, has emerged as a critical contributor to brain aging. Senescent cells accumulate with age, driven by the p53-p21 and p16-pRb pathways, and secrete pro-inflammatory factors via senescence-associated secretory phenotype (SASP), thereby exacerbating neurodegeneration, vascular dysfunction, and cognitive decline. Extracellular vesicles (EVs) are natural nanocarriers of proteins, lipids, and nucleic acids, and have emerged as key mediators of intercellular communication and therapeutics for aging and age-related conditions. EVs derived from various cell types, such as mesenchymal stem cells (MSCs), neural stem cells (NSCs), and induced pluripotent stem cells (iPSCs), can modulate senescence-related pathways, reduce inflammation, and promote tissue repair. Preclinical studies demonstrate that stem-cell-derived EVs can improve cognitive performance, enhance neurogenesis, reduce senescence phenotype, improve neuronal survival through neuroprotective miRNAs (miR-181a-2-3p), suppress neuroinflammation via inhibition of NLRP3 inflammasome, and support synaptic plasticity. Stem cell EVs possess natural biocompatibility, the ability to cross the blood-brain barrier (BBB), and targeted delivery mechanisms, making them promising candidates for anti-aging interventions. This review elaborates on the multifaceted role of stem cell EVs in mitigating brain aging, senescence, and age-associated chronic disease phenotype.
Related Topics
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.20517/evcna.2025.65
- OA Status
- green
- References
- 144
- OpenAlex ID
- https://openalex.org/W4414673451
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4414673451Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.20517/evcna.2025.65Digital Object Identifier
- Title
-
Stem-cell-derived extracellular vesicles in neurodegeneration and neuroaging: therapeutic potential and challengesWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-09-30Full publication date if available
- Authors
-
Mohit Kumar, Sudipta Ray, Susmita SilList of authors in order
- Landing page
-
https://doi.org/10.20517/evcna.2025.65Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/12540269Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
144Number of works referenced by this work
Full payload
| id | https://openalex.org/W4414673451 |
|---|---|
| doi | https://doi.org/10.20517/evcna.2025.65 |
| ids.doi | https://doi.org/10.20517/evcna.2025.65 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41132506 |
| ids.openalex | https://openalex.org/W4414673451 |
| fwci | 0.0 |
| type | review |
| title | Stem-cell-derived extracellular vesicles in neurodegeneration and neuroaging: therapeutic potential and challenges |
| biblio.issue | 3 |
| biblio.volume | 6 |
| biblio.last_page | 608 |
| biblio.first_page | 594 |
| topics[0].id | https://openalex.org/T10773 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1312 |
| topics[0].subfield.display_name | Molecular Biology |
| topics[0].display_name | Extracellular vesicles in disease |
| topics[1].id | https://openalex.org/T10062 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9972000122070312 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1306 |
| topics[1].subfield.display_name | Cancer Research |
| topics[1].display_name | MicroRNA in disease regulation |
| topics[2].id | https://openalex.org/T11266 |
| topics[2].field.id | https://openalex.org/fields/28 |
| topics[2].field.display_name | Neuroscience |
| topics[2].score | 0.9909999966621399 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2808 |
| topics[2].subfield.display_name | Neurology |
| topics[2].display_name | Neuroinflammation and Neurodegeneration Mechanisms |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| language | en |
| locations[0].id | doi:10.20517/evcna.2025.65 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S4210237820 |
| locations[0].source.issn | 2767-6641 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 2767-6641 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Extracellular Vesicles and Circulating Nucleic Acids |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].source.host_organization_lineage | |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Extracellular Vesicles and Circulating Nucleic Acids |
| locations[0].landing_page_url | https://doi.org/10.20517/evcna.2025.65 |
| locations[1].id | pmid:41132506 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Extracellular vesicles and circulating nucleic acids |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41132506 |
| locations[2].id | pmh:oai:europepmc.org:11348154 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12540269 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5054930574 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-0083-7217 |
| authorships[0].author.display_name | Mohit Kumar |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I59130452 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA. |
| authorships[0].institutions[0].id | https://openalex.org/I59130452 |
| authorships[0].institutions[0].ror | https://ror.org/00thqtb16 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I59130452 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | University of Nebraska Medical Center |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Mohit Kumar |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA. |
| authorships[1].author.id | https://openalex.org/A5048706356 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-3889-0136 |
| authorships[1].author.display_name | Sudipta Ray |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I59130452 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA. |
| authorships[1].institutions[0].id | https://openalex.org/I59130452 |
| authorships[1].institutions[0].ror | https://ror.org/00thqtb16 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I59130452 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | University of Nebraska Medical Center |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Sudipta Ray |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA. |
| authorships[2].author.id | https://openalex.org/A5008811013 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-8941-985X |
| authorships[2].author.display_name | Susmita Sil |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I59130452 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA. |
| authorships[2].institutions[0].id | https://openalex.org/I59130452 |
| authorships[2].institutions[0].ror | https://ror.org/00thqtb16 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I59130452 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | University of Nebraska Medical Center |
| authorships[2].author_position | last |
| authorships[2].raw_author_name | Susmita Sil |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12540269 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Stem-cell-derived extracellular vesicles in neurodegeneration and neuroaging: therapeutic potential and challenges |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10773 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1312 |
| primary_topic.subfield.display_name | Molecular Biology |
| primary_topic.display_name | Extracellular vesicles in disease |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:europepmc.org:11348154 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306400806 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Europe PMC (PubMed Central) |
| best_oa_location.source.host_organization | https://openalex.org/I1303153112 |
| best_oa_location.source.host_organization_name | European Bioinformatics Institute |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1303153112 |
| best_oa_location.license | other-oa |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | https://openalex.org/licenses/other-oa |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12540269 |
| primary_location.id | doi:10.20517/evcna.2025.65 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S4210237820 |
| primary_location.source.issn | 2767-6641 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 2767-6641 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Extracellular Vesicles and Circulating Nucleic Acids |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.source.host_organization_lineage | |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Extracellular Vesicles and Circulating Nucleic Acids |
| primary_location.landing_page_url | https://doi.org/10.20517/evcna.2025.65 |
| publication_date | 2025-09-30 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4389731931, https://openalex.org/W4398774059, https://openalex.org/W3119985674, https://openalex.org/W4213091566, https://openalex.org/W3111207111, https://openalex.org/W4220766422, https://openalex.org/W4308298493, https://openalex.org/W3006354165, https://openalex.org/W2123352493, https://openalex.org/W4403733421, https://openalex.org/W4362641068, https://openalex.org/W3088158882, https://openalex.org/W2993497584, https://openalex.org/W4412884005, https://openalex.org/W4293527318, https://openalex.org/W2047874895, https://openalex.org/W4412822559, https://openalex.org/W3013022529, https://openalex.org/W4200534156, https://openalex.org/W4400079385, https://openalex.org/W2780553069, https://openalex.org/W4296391795, https://openalex.org/W3123843327, https://openalex.org/W2027272551, https://openalex.org/W4401616283, https://openalex.org/W4395696997, https://openalex.org/W4403588594, https://openalex.org/W4401218296, https://openalex.org/W4410089852, https://openalex.org/W4408231483, https://openalex.org/W4401413210, https://openalex.org/W4360810562, https://openalex.org/W4396764686, https://openalex.org/W4318067741, https://openalex.org/W4310496865, https://openalex.org/W4386194378, https://openalex.org/W2097049162, https://openalex.org/W4391116790, https://openalex.org/W4378212353, https://openalex.org/W4400590371, https://openalex.org/W4395001289, https://openalex.org/W2108375854, https://openalex.org/W2962176767, https://openalex.org/W3086478659, https://openalex.org/W4405334948, https://openalex.org/W3157511827, https://openalex.org/W3028124638, https://openalex.org/W3175012470, https://openalex.org/W4388116720, https://openalex.org/W2401862951, https://openalex.org/W4390744242, https://openalex.org/W4294168561, https://openalex.org/W4400132518, https://openalex.org/W4404595680, https://openalex.org/W4403759825, https://openalex.org/W4403918749, https://openalex.org/W4399781663, https://openalex.org/W4362672420, https://openalex.org/W3206218751, https://openalex.org/W3038064374, https://openalex.org/W4409021505, https://openalex.org/W4401237478, https://openalex.org/W4392763271, https://openalex.org/W4382651770, https://openalex.org/W3126779750, https://openalex.org/W4385811138, https://openalex.org/W4312113305, https://openalex.org/W2069270259, https://openalex.org/W2064682255, https://openalex.org/W2035228196, https://openalex.org/W2020031936, https://openalex.org/W2037850102, https://openalex.org/W4379106457, https://openalex.org/W2094016424, https://openalex.org/W4412387966, https://openalex.org/W2998345901, https://openalex.org/W2095916019, https://openalex.org/W4402568170, https://openalex.org/W2018716983, https://openalex.org/W2969342093, https://openalex.org/W1976085004, https://openalex.org/W2104230351, https://openalex.org/W2049502009, https://openalex.org/W4410391229, https://openalex.org/W2044619408, https://openalex.org/W4389299208, https://openalex.org/W4386387088, https://openalex.org/W2008386957, https://openalex.org/W3108226754, https://openalex.org/W3014489707, https://openalex.org/W2989415456, https://openalex.org/W4385758665, https://openalex.org/W4323074786, https://openalex.org/W4377205837, https://openalex.org/W4406814558, https://openalex.org/W4205733268, https://openalex.org/W4409570654, https://openalex.org/W4409197420, https://openalex.org/W3090865474, https://openalex.org/W2146316688, https://openalex.org/W3132285226, https://openalex.org/W2305994285, https://openalex.org/W3177863019, https://openalex.org/W4318829306, https://openalex.org/W966495834, https://openalex.org/W4311744984, https://openalex.org/W4391144646, https://openalex.org/W2889787710, https://openalex.org/W3042580583, https://openalex.org/W3174664487, https://openalex.org/W4403965182, https://openalex.org/W4409241166, https://openalex.org/W4405457019, https://openalex.org/W2888559669, https://openalex.org/W4213324992, https://openalex.org/W3010320321, https://openalex.org/W2928157366, https://openalex.org/W3216516063, https://openalex.org/W2890865075, https://openalex.org/W3124591628, https://openalex.org/W4301391517, https://openalex.org/W4380538441, https://openalex.org/W3135053615, https://openalex.org/W4404069580, https://openalex.org/W4390964116, https://openalex.org/W4401887670, https://openalex.org/W4362631142, https://openalex.org/W2037601979, https://openalex.org/W2601048487, https://openalex.org/W2211190951, https://openalex.org/W4206935014, https://openalex.org/W3018217038, https://openalex.org/W4409603461, https://openalex.org/W2786514708, https://openalex.org/W4411228387, https://openalex.org/W4379645264, https://openalex.org/W3005104290, https://openalex.org/W4410498984, https://openalex.org/W4394859534, https://openalex.org/W3017240959, https://openalex.org/W2982668686, https://openalex.org/W4404929771, https://openalex.org/W2900756811, https://openalex.org/W4229377541 |
| referenced_works_count | 144 |
| abstract_inverted_index.a | 2, 57, 67 |
| abstract_inverted_index.At | 22 |
| abstract_inverted_index.as | 66, 117, 137 |
| abstract_inverted_index.by | 15, 31, 79 |
| abstract_inverted_index.in | 6, 231 |
| abstract_inverted_index.is | 1, 29 |
| abstract_inverted_index.of | 59, 108, 120, 188, 227 |
| abstract_inverted_index.on | 223 |
| abstract_inverted_index.to | 70, 203 |
| abstract_inverted_index.EVs | 130, 167, 197, 230 |
| abstract_inverted_index.and | 19, 25, 49, 82, 85, 99, 111, 114, 123, 127, 146, 158, 191, 209, 236 |
| abstract_inverted_index.are | 105 |
| abstract_inverted_index.can | 152, 168 |
| abstract_inverted_index.for | 125, 217 |
| abstract_inverted_index.has | 64 |
| abstract_inverted_index.key | 118 |
| abstract_inverted_index.the | 8, 23, 80, 201, 205, 224 |
| abstract_inverted_index.via | 89, 186 |
| abstract_inverted_index.Stem | 195 |
| abstract_inverted_index.This | 220 |
| abstract_inverted_index.age, | 77 |
| abstract_inverted_index.cell | 47, 61, 134, 196, 229 |
| abstract_inverted_index.from | 132 |
| abstract_inverted_index.have | 115 |
| abstract_inverted_index.role | 226 |
| abstract_inverted_index.stem | 46, 139, 143, 149, 228 |
| abstract_inverted_index.such | 136 |
| abstract_inverted_index.that | 165 |
| abstract_inverted_index.them | 214 |
| abstract_inverted_index.with | 76 |
| abstract_inverted_index.(EVs) | 104 |
| abstract_inverted_index.Among | 53 |
| abstract_inverted_index.NLRP3 | 189 |
| abstract_inverted_index.aging | 28, 126 |
| abstract_inverted_index.brain | 9, 71, 233 |
| abstract_inverted_index.cells | 74, 140, 144, 150 |
| abstract_inverted_index.cross | 204 |
| abstract_inverted_index.cycle | 62 |
| abstract_inverted_index.loss, | 17 |
| abstract_inverted_index.state | 58 |
| abstract_inverted_index.which | 7 |
| abstract_inverted_index.(BBB), | 208 |
| abstract_inverted_index.acids, | 113 |
| abstract_inverted_index.aging, | 234 |
| abstract_inverted_index.aging. | 72 |
| abstract_inverted_index.driven | 30, 78 |
| abstract_inverted_index.level, | 27 |
| abstract_inverted_index.making | 213 |
| abstract_inverted_index.marked | 14 |
| abstract_inverted_index.miRNAs | 182 |
| abstract_inverted_index.neural | 142 |
| abstract_inverted_index.reduce | 156, 174 |
| abstract_inverted_index.review | 221 |
| abstract_inverted_index.these, | 54 |
| abstract_inverted_index.tissue | 160 |
| abstract_inverted_index.types, | 135 |
| abstract_inverted_index.(MSCs), | 141 |
| abstract_inverted_index.(NSCs), | 145 |
| abstract_inverted_index.(SASP), | 93 |
| abstract_inverted_index.ability | 202 |
| abstract_inverted_index.altered | 50 |
| abstract_inverted_index.arrest, | 63 |
| abstract_inverted_index.barrier | 207 |
| abstract_inverted_index.chronic | 238 |
| abstract_inverted_index.complex | 3 |
| abstract_inverted_index.decline | 13 |
| abstract_inverted_index.derived | 131 |
| abstract_inverted_index.disease | 239 |
| abstract_inverted_index.emerged | 65, 116 |
| abstract_inverted_index.enhance | 172 |
| abstract_inverted_index.factors | 88 |
| abstract_inverted_index.genomic | 36 |
| abstract_inverted_index.improve | 169, 177 |
| abstract_inverted_index.induced | 147 |
| abstract_inverted_index.lipids, | 110 |
| abstract_inverted_index.natural | 106, 199 |
| abstract_inverted_index.nucleic | 112 |
| abstract_inverted_index.p16-pRb | 83 |
| abstract_inverted_index.p53-p21 | 81 |
| abstract_inverted_index.possess | 198 |
| abstract_inverted_index.process | 5 |
| abstract_inverted_index.promote | 159 |
| abstract_inverted_index.repair. | 161 |
| abstract_inverted_index.secrete | 86 |
| abstract_inverted_index.studies | 163 |
| abstract_inverted_index.support | 192 |
| abstract_inverted_index.thereby | 94 |
| abstract_inverted_index.through | 180 |
| abstract_inverted_index.various | 133 |
| abstract_inverted_index.(iPSCs), | 151 |
| abstract_inverted_index.cellular | 26, 44, 55 |
| abstract_inverted_index.critical | 68 |
| abstract_inverted_index.decline. | 21, 101 |
| abstract_inverted_index.delivery | 211 |
| abstract_inverted_index.modulate | 153 |
| abstract_inverted_index.multiple | 32 |
| abstract_inverted_index.neuronal | 178 |
| abstract_inverted_index.suppress | 184 |
| abstract_inverted_index.survival | 179 |
| abstract_inverted_index.synaptic | 16, 193 |
| abstract_inverted_index.targeted | 210 |
| abstract_inverted_index.telomere | 38 |
| abstract_inverted_index.vascular | 97 |
| abstract_inverted_index.vesicles | 103 |
| abstract_inverted_index.Senescent | 73 |
| abstract_inverted_index.cognitive | 20, 100, 170 |
| abstract_inverted_index.including | 35 |
| abstract_inverted_index.mediators | 119 |
| abstract_inverted_index.molecular | 24 |
| abstract_inverted_index.pathways, | 84, 155 |
| abstract_inverted_index.phenotype | 92 |
| abstract_inverted_index.promising | 215 |
| abstract_inverted_index.proteins, | 109 |
| abstract_inverted_index.secretory | 91 |
| abstract_inverted_index.undergoes | 10 |
| abstract_inverted_index.Neuroaging | 0 |
| abstract_inverted_index.accumulate | 75 |
| abstract_inverted_index.anti-aging | 218 |
| abstract_inverted_index.attrition, | 39 |
| abstract_inverted_index.biological | 4 |
| abstract_inverted_index.candidates | 216 |
| abstract_inverted_index.elaborates | 222 |
| abstract_inverted_index.epigenetic | 40 |
| abstract_inverted_index.functional | 12 |
| abstract_inverted_index.hallmarks, | 34 |
| abstract_inverted_index.inhibition | 187 |
| abstract_inverted_index.mitigating | 232 |
| abstract_inverted_index.phenotype, | 176 |
| abstract_inverted_index.phenotype. | 240 |
| abstract_inverted_index.senescence | 175 |
| abstract_inverted_index.Preclinical | 162 |
| abstract_inverted_index.age-related | 128 |
| abstract_inverted_index.blood-brain | 206 |
| abstract_inverted_index.conditions. | 129 |
| abstract_inverted_index.contributor | 69 |
| abstract_inverted_index.demonstrate | 164 |
| abstract_inverted_index.exhaustion, | 48 |
| abstract_inverted_index.mechanisms, | 212 |
| abstract_inverted_index.mesenchymal | 138 |
| abstract_inverted_index.plasticity. | 194 |
| abstract_inverted_index.pluripotent | 148 |
| abstract_inverted_index.progressive | 11 |
| abstract_inverted_index.senescence, | 45, 56, 235 |
| abstract_inverted_index.alterations, | 41 |
| abstract_inverted_index.dysfunction, | 43, 98 |
| abstract_inverted_index.exacerbating | 95 |
| abstract_inverted_index.instability, | 37 |
| abstract_inverted_index.irreversible | 60 |
| abstract_inverted_index.multifaceted | 225 |
| abstract_inverted_index.nanocarriers | 107 |
| abstract_inverted_index.performance, | 171 |
| abstract_inverted_index.therapeutics | 124 |
| abstract_inverted_index.Extracellular | 102 |
| abstract_inverted_index.communication | 122 |
| abstract_inverted_index.inflammasome, | 190 |
| abstract_inverted_index.inflammation, | 157 |
| abstract_inverted_index.intercellular | 51, 121 |
| abstract_inverted_index.mitochondrial | 42 |
| abstract_inverted_index.neurogenesis, | 173 |
| abstract_inverted_index.age-associated | 237 |
| abstract_inverted_index.communication. | 52 |
| abstract_inverted_index.interconnected | 33 |
| abstract_inverted_index.interventions. | 219 |
| abstract_inverted_index.neuroprotective | 181 |
| abstract_inverted_index.(miR-181a-2-3p), | 183 |
| abstract_inverted_index.pro-inflammatory | 87 |
| abstract_inverted_index.biocompatibility, | 200 |
| abstract_inverted_index.neuroinflammation | 185 |
| abstract_inverted_index.stem-cell-derived | 166 |
| abstract_inverted_index.neurodegeneration, | 96 |
| abstract_inverted_index.neuroinflammation, | 18 |
| abstract_inverted_index.senescence-related | 154 |
| abstract_inverted_index.senescence-associated | 90 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 3 |
| citation_normalized_percentile.value | 0.44552774 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |